FFA
PCVX icon

Farther Finance Advisors’s Vaxcyte PCVX Stock Holding History

Farther Finance Advisors’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.7K Buy
470
+71
+18% +$4.14K ﹤0.01% 3909
2026
Q2 		$23.1K Sell
399
-159
-28% -$8.64K ﹤0.01% 3870
2026
Q1 		$32.6K Buy
558
+215
+63% +$11.7K ﹤0.01% 3303
2025
Q4 		$15.8K Buy
343
+122
+55% +$5.46K ﹤0.01% 3597
2025
Q3 		$7.96K Buy
221
+85
+63% +$2.82K ﹤0.01% 3543
2025
Q2 		$4.42K Buy
136
+37
+37% +$1.21K ﹤0.01% 3407
2025
Q1 		$3.19K Buy
99
+6
+6% +$480 ﹤0.01% 3222
2024
Q4 		$7.61K Buy
93
+7
+8% +$695 ﹤0.01% 2484
2024
Q3 		$9.83K Buy
86
+9
+12% +$811 ﹤0.01% 2379
2024
Q2 		$5.92K Buy
77
+10
+15% +$681 ﹤0.01% 2323
2024
Q1 		$4.47K Hold
67
– – ﹤0.01% 2122
2023
Q4 		$4.21K Buy
67
+60
+857% +$3.12K ﹤0.01% 2057
2023
Q3 		$357 Buy
7
+5
+250% +$247 ﹤0.01% 2345
2023
Q2 		$100 Buy
+2
New +$95 ﹤0.01% 2426

Other funds holding PCVX

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

Farther Finance Advisors's PCVX Position: Q3 2026 in Review

Farther Finance Advisors increased its Vaxcyte (PCVX) stake by 18% in Q3 2026, buying an estimated $4.14K and bringing the position to 470 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3909.

Farther Finance Advisors first reported a position in PCVX in Q2 2023 and has held it in 14 quarters since. The position peaked at $32.6K in Q1 2026. 8 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Farther Finance Advisors held 470 shares of Vaxcyte worth $26.7K as of Q3 2026.
  • Farther Finance Advisors bought 71 Vaxcyte shares in Q3 2026, an estimated $4.14K.
  • Vaxcyte made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3909 holding.
  • Farther Finance Advisors first reported a position in Vaxcyte in Q2 2023 and has held it in 14 quarters since.
  • Farther Finance Advisors's Vaxcyte position peaked at $32.6K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.